Global Elastomeric Infusion Pumps Market Forecast
- Global elastomeric infusion pumps market size to reach US$1,900 Bn in 2031, up from US$981 Mn attained in 2024
- Market revenue projected to exhibit a remarkable rate of expansion, at an estimated CAGR of 9.9% during 2024 - 2031
Quick Report Digest
- Factors driving market growth include the rise in chronic illnesses, popularity of home-based treatments, and technological advancements in pump design.
- Key growth determinants include ongoing technological innovations, increasing burden of chronic diseases, and the growing preference for home healthcare services.
- Major growth barriers involve regulatory compliance, competition from alternative drug delivery systems, and limited reimbursement coverage.
- Key trends include a focus on sustainable practices, continuous technological innovation, and expansion into emerging markets.
- The regulatory scenario shapes the industry significantly, impacting market entry, reimbursement policies, and material compatibility.
- Continuous rate elastomeric pumps dominate the market due to their consistent drug delivery, portability, and cost-effectiveness.
- Variable rate elastomeric pumps offer flexibility in drug delivery tailored to individual patient needs, particularly valuable in critical care settings.
- North America leads the market due to advanced healthcare infrastructure, while Europe drives growth with a rising geriatric population and healthcare initiatives.
- Key players in the market include Baxter International, Fresenius Kabi AG, B. Braun Melsungen AG, focusing on product innovation and strategic partnerships for market dominance.
A Look Back and a Look Forward - Comparative Analysis
The elastomeric infusion pumps market is on a steady climb towards a promising future. Analysts believe it experienced significant growth in recent years, fuelled by several key factors. The rise of chronic illnesses requiring continuous medication is driving demand for these pumps. The growing popularity of home-based infusions, allowing for more convenient treatment, is a major boost.
Advancements in the technology itself, with longer durations, improved accuracy, and lower infection risks, are making elastomeric pumps even more attractive. This momentum is expected to continue, with analysts predicting a healthy CAGR in the coming years.
The inherent advantages of these pumps - portability, ease of use, and cost-effectiveness - combined with an aging population with chronic conditions and a growing need for convenient home healthcare, will all contribute to market expansion. This trajectory positions elastomeric infusion pumps as a leader in drug delivery, solidifying their place as a preferred choice for both patients and healthcare providers.
Key Growth Determinants
- Technological Advancements
Ongoing technological advancements, such as the development of smart pumps with features like remote monitoring and dosage control, are driving growth in the elastomeric infusion pumps market. These innovations enhance patient convenience, increase accuracy in drug delivery, and improve overall treatment outcomes, thereby fuelling market expansion.
- Rising Chronic Disease Burden
The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, necessitates long-term medication administration. Elastomeric infusion pumps offer a cost-effective and convenient solution for continuous drug delivery outside of healthcare facilities, contributing to their rising adoption and market growth.
- Growing Home Healthcare Sector
With a growing preference for home-based healthcare services, there is a significant demand for portable and easy-to-use medical devices like elastomeric infusion pumps. These pumps allow patients to receive necessary medications at home, reducing the need for frequent hospital visits and improving patient comfort.
The expanding home healthcare sector, coupled with advancements in elastomeric pump technology, is driving market growth as it provides patients with greater autonomy over their treatment regimens.Top of Form
Major Growth Barriers
- Regulatory Compliance
Stringent regulations and approval processes imposed by health authorities can significantly hinder the growth of the elastomeric infusion pumps market.
Compliance with these regulations often requires extensive clinical trials, documentation, and quality assurance measures, which can increase time-to-market and operational costs for manufacturers.
- Competitive Pressure
The elastomeric infusion pumps market faces intense competition from alternative drug delivery systems such as electronic infusion pumps and intravenous (IV) infusion sets. These alternatives may offer advanced features, precise dosage control, and greater patient convenience, posing a challenge to the growth of elastomeric pumps.
- Limited Reimbursement Coverage
Reimbursement policies and coverage for elastomeric infusion pumps vary geographically and may be limited compared to other infusion pump options. Limited reimbursement can deter healthcare facilities and patients from adopting elastomeric pumps, particularly in regions where healthcare budgets are constrained, or reimbursement rates are low. This limitation can impede market growth by affecting demand and adoption rates.
Key Trends and Opportunities to Look at
- Sustainable Practices
There is a growing emphasis on sustainability across industries, including healthcare. Consumers are increasingly aware of environmental issues and are demanding eco-friendly products and practices from companies.
In the healthcare sector, there's a push towards reducing medical waste, improving energy efficiency, and using environmentally friendly materials in medical devices, and equipment.
- Technological Innovation
Investing in research and development to innovate new technologies can provide a competitive edge in the market. For instance, developing smart infusion pumps equipped with sensors and connectivity features can enable real-time monitoring of medication delivery, enhancing patient safety and treatment efficacy.
Additionally, incorporating advancements in materials science can lead to the development of more durable and biocompatible infusion pump components, improving product performance and reliability.
- Expansion in Developing Markets
Expanding into emerging markets presents significant growth opportunities for Elastomeric Infusion Pump Market players. Countries in Asia Pacific, Latin America, and Africa are witnessing increasing healthcare expenditure and improving healthcare infrastructure, creating a demand for advanced medical devices and treatments.
By establishing strategic partnerships with local distributors or healthcare providers and adapting their products to meet the specific needs of these markets, companies can tap into this growing customer base and drive revenue growth.
How Does the Regulatory Scenario Shape this Industry?
The regulatory landscape significantly influences the elastomeric infusion pumps market. Strict regulations ensure safety and efficacy, driving the need for pumps that comply with stringent standards.
This fosters competition among manufacturers to develop high-quality devices. Rigorous approval processes, however, can delay market entry for new pumps, impacting growth. But it ensures patient safety and eliminates potentially harmful devices. Reimbursement policies by insurance agencies affect market adoption.
Wider coverage for elastomeric infusion pumps and specific treatments can increase market demand. Regulations regarding material compatibility influence pump design and component selection.
Manufacturers need to ensure materials used are compatible with the drugs being delivered to prevent degradation or contamination. Evolving environmental regulations regarding waste disposal of elastomeric pumps can impact production costs. Manufacturers may need to adopt eco-friendly practices or invest in proper disposal mechanisms.
Fairfield’s Ranking Board
Top Segments
Continuous Rate Elastomeric Pumps Command a Dominant Market Share
Continuous rate elastomeric pumps dominate the elastomeric infusion pumps market due to their consistent and predictable drug delivery mechanism. These pumps are widely used in scenarios where a steady infusion rate is crucial for patient treatment, such as in pain management or chemotherapy.
Their simplicity, portability, and cost-effectiveness make them preferred choices for both healthcare providers and patients. Continuous rate pumps offer a hassle-free solution, requiring minimal supervision once set up, thus enhancing patient mobility and comfort.
With advancements in technology, continuous rate elastomeric pumps continue to evolve, offering features like adjustable flow rates and improved safety mechanisms, further widening their application in various medical settings.
Significant Growth Prospects Await Variable Rate Elastomeric Pumps
Variable rate elastomeric pumps are gaining traction in the elastomeric infusion pumps market owing to their flexibility in drug delivery tailored to individual patient needs. These pumps allow healthcare providers to adjust infusion rates according to changing therapeutic requirements, offering personalised treatment approaches.
Variable rate pumps are particularly valuable in conditions where medication dosages need to be titrated or varied over time, such as in critical care or ambulatory settings. Their ability to accommodate fluctuations in patient condition ensures precise medication administration, minimising the risk of under or overdosing.
Additionally, variable rate elastomeric pumps facilitate therapeutic optimisation, enabling healthcare providers to fine-tune treatment strategies for improved patient outcomes. As demand for personalised medicine grows, variable rate pumps are anticipated to witness continued adoption and technological enhancements, further expanding their market presence.
Regional Frontrunners
North America Leads the Way
North America commands a prominent position in the elastomeric infusion pumps market due to several key factors. The region's advanced healthcare infrastructure, substantial healthcare expenditure, and the presence of major market players contribute significantly to its dominance.
Additionally, the increasing prevalence of chronic diseases such as cancer and diabetes drives demand for infusion pumps, including elastomeric ones. Favourable reimbursement policies and growing patient awareness further augment market growth, making North America a leading regional market for elastomeric infusion pumps.
Europe Emerges as the Most Significant Market
Europe emerges as a pivotal region in the elastomeric infusion pumps market, driven by various factors. The region's rising geriatric population, high prevalence of chronic diseases, and government initiatives supporting healthcare play crucial roles in propelling market expansion.
Furthermore, advancements in healthcare technology and the growing adoption of home healthcare services contribute to the increasing demand for elastomeric infusion pumps. Strategic initiatives by market players, such as product launches and collaborations, further bolster market growth in Europe.
Fairfield’s Competitive Landscape Analysis
The competition landscape in the elastomeric infusion pumps market is characterised by intense rivalry among key players striving for market dominance. Leading players such as Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Smiths Medical are prominent in this space.
These companies employ various growth strategies to maintain their competitive edge, including product innovation, strategic partnerships, mergers and acquisitions, and geographical expansions. For instance, they continuously invest in R&D to develop advanced elastomeric infusion pump technologies, enhancing product efficiency and patient comfort.
Additionally, strategic collaborations with healthcare providers and distributors help in expanding their market reach and penetration. Furthermore, acquisitions of smaller firms with complementary product portfolios enable these companies to broaden their product offerings and strengthen their market position.
Overall, the elastomeric infusion pumps market witnesses dynamic competition driven by innovation and strategic initiatives aimed at catering to the evolving needs of healthcare professionals and patients.
Who are the Leaders in the Elastomeric Infusion Pumps Market Space?
- Baxter International, Inc.
- Fresenius Kabi AG
- B. Braun Melsungen AG
- Ambu A/S
- Leventon, S.A.U.
- Nipro Corporation
- Terumo Corporation
- Avanos Medical, Inc.
An Expert’s Eye
Increasing Prevalence of Chronic Diseases
With a rise in chronic diseases such as cancer, diabetes, and cardiovascular disorders, there is a growing demand for continuous medication delivery. Elastomeric infusion pumps offer a convenient solution for administering medications over an extended period, driving market growth.
Advancements in Healthcare Infrastructure
Developing regions are witnessing improvements in healthcare infrastructure and accessibility. This facilitates the adoption of advanced medical technologies including elastomeric infusion pumps, thereby expanding the market size globally.
Preference for Home Healthcare
There is a notable shift towards home-based healthcare solutions, driven by factors like convenience, cost-effectiveness, and patient preference. Elastomeric infusion pumps enable patients to receive continuous medication at home, thereby fuelling market expansion.
The Global Elastomeric Infusion Pumps Market is Segmented as Below:
Elastomeric Infusion Pumps Market by Product
- Continuous Rate Elastomeric Pumps
- Variable Rate Elastomeric Pumps
Elastomeric Infusion Pumps Market by Treatment
- Pain Management
- Antibiotic/Antiviral
- Chemotherapy
- Others
Elastomeric Infusion Pumps Market by End User
- Hospitals
- Ambulatory Surgical Centres
- Home Care Settings
- Clinics
- Others
Elastomeric Infusion Pumps Market by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Turkey
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Egypt
- Nigeria
- Rest of the Middle East & Africa
1. Executive Summary
1.1. Global Elastomeric Infusion Pumps Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
3.1. Global Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Continuous Rate Elastomeric Pumps
3.1.1.2. Variable Rate Elastomeric Pumps
3.2. Global Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Pain Management
3.2.1.2. Antibiotic/Antiviral
3.2.1.3. Chemotherapy
3.2.1.4. Others
3.3. Global Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Ambulatory Surgical Centers
3.3.1.3. Home Care Settings
3.3.1.4. Clinics
3.3.1.5. Others
3.4. Global Elastomeric Infusion Pumps Market Outlook, by Region, Value (US$ Mn), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
4.1. North America Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Continuous Rate Elastomeric Pumps
4.1.1.2. Variable Rate Elastomeric Pumps
4.2. North America Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Pain Management
4.2.1.2. Antibiotic/Antiviral
4.2.1.3. Chemotherapy
4.2.1.4. Others
4.3. North America Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Ambulatory Surgical Centers
4.3.1.3. Home Care Settings
4.3.1.4. Clinics
4.3.1.5. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
4.4.1.2. U.S. Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
4.4.1.3. U.S. Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
4.4.1.4. Canada Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
4.4.1.5. Canada Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
4.4.1.6. Canada Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
5.1. Europe Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Continuous Rate Elastomeric Pumps
5.1.1.2. Variable Rate Elastomeric Pumps
5.2. Europe Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Pain Management
5.2.1.2. Antibiotic/Antiviral
5.2.1.3. Chemotherapy
5.2.1.4. Others
5.3. Europe Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centers
5.3.1.3. Home Care Settings
5.3.1.4. Clinics
5.3.1.5. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.2. Germany Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.3. Germany Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.4. U.K. Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.5. U.K. Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.6. U.K. Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.7. France Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.8. France Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.9. France Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.10. Italy Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.11. Italy Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.12. Italy Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.13. Turkey Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.14. Turkey Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.15. Turkey Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.16. Russia Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.17. Russia Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.18. Russia Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.1.19. Rest of Europe Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
5.4.1.20. Rest of Europe Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
5.4.1.21. Rest of Europe Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
6.1. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Continuous Rate Elastomeric Pumps
6.1.1.2. Variable Rate Elastomeric Pumps
6.2. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Pain Management
6.2.1.2. Antibiotic/Antiviral
6.2.1.3. Chemotherapy
6.2.1.4. Others
6.3. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centers
6.3.1.3. Home Care Settings
6.3.1.4. Clinics
6.3.1.5. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. China Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.2. China Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.3. China Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.4. Japan Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.5. Japan Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.6. Japan Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.7. South Korea Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.8. South Korea Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.9. South Korea Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.10. India Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.11. India Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.12. India Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.13. Southeast Asia Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.14. Southeast Asia Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.15. Southeast Asia Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.1.16. Rest of Asia Pacific Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
6.4.1.17. Rest of Asia Pacific Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
6.4.1.18. Rest of Asia Pacific Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
7.1. Latin America Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Continuous Rate Elastomeric Pumps
7.1.1.2. Variable Rate Elastomeric Pumps
7.2. Latin America Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Pain Management
7.2.1.2. Antibiotic/Antiviral
7.2.1.3. Chemotherapy
7.2.1.4. Others
7.3. Latin America Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centers
7.3.1.3. Home Care Settings
7.3.1.4. Clinics
7.3.1.5. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.2. Brazil Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.3. Brazil Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.1.4. Mexico Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.5. Mexico Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.6. Mexico Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.1.7. Argentina Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.8. Argentina Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.9. Argentina Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.1.10. Rest of Latin America Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
7.4.1.11. Rest of Latin America Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
7.4.1.12. Rest of Latin America Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, 2019 - 2031
8.1. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by Product, Value (US$ Mn), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Continuous Rate Elastomeric Pumps
8.1.1.2. Variable Rate Elastomeric Pumps
8.2. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by Treatment, Value (US$ Mn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Pain Management
8.2.1.2. Antibiotic/Antiviral
8.2.1.3. Chemotherapy
8.2.1.4. Others
8.3. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by End User, Value (US$ Mn), 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centers
8.3.1.3. Home Care Settings
8.3.1.4. Clinics
8.3.1.5. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Elastomeric Infusion Pumps Market Outlook, by Country, Value (US$ Mn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.2. GCC Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.3. GCC Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.4. South Africa Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.5. South Africa Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.6. South Africa Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.7. Egypt Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.8. Egypt Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.9. Egypt Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.10. Nigeria Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.11. Nigeria Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.12. Nigeria Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.1.13. Rest of Middle East & Africa Elastomeric Infusion Pumps Market by Product, Value (US$ Mn), 2019 - 2031
8.4.1.14. Rest of Middle East & Africa Elastomeric Infusion Pumps Market by Treatment, Value (US$ Mn), 2019 - 2031
8.4.1.15. Rest of Middle East & Africa Elastomeric Infusion Pumps Market by End User, Value (US$ Mn), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Treatment Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Baxter International, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Fresenius Kabi AG
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. B. Braun Melsungen AG
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Ambu A/S
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Leventon, S.A.U.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Nipro Corporation
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Terumo Corporation
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Avanos Medical, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
|
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
 |
2023 |
 |
2019 - 2023 |
 |
2024 - 2031 |
Value: US$ Billion |
|
REPORT FEATURES |
DETAILS |
|
Product Coverage |
|
|
Treatment Coverage |
|
|
End User Coverage |
|
|
Geographical Coverage |
|
|
Leading Companies |
|
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis, Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Quality assured
